Women with ovarian cancer exceeded the study goal of 150 minutes of brisk walking per week. Those in the exercise group also scored significantly better than controls on measures of fatigue. No ...

The accuracy of the cancer antigen (CA)–125 test in predicting ovarian cancer varies by ethnicity, primarily due to factors like age and comorbidities rather than ethnicity itself. General ...

(HealthDay News) – For women with ovarian cancer, metformin use is associated with significantly improved survival, according to a study published online Dec. 3 in Cancer. To examine the association ...

Neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) is an effective treatment for women with advanced ovarian cancer. Many women treated with NACT do not undergo IDS, and ...

Current treatment guidelines recommend using cancer antigen-125 (CA-125) as a diagnostic marker for ovarian cancer recurrence, but a recent study suggests CA-125 has poor concordance with progressive ...

HealthDay News — Ovarian cancer isn’t a single disease, but rather a number of different malignancies involving the ovaries, an expert U.S. panel says. Evidence suggests that many ovarian cancers ...

CA-125 is a “useful test” for ovarian cancer in primary care, especially in symptomatic women aged older than 50 years, according to a presenter at the recent National Cancer Research Institute Cancer ...

The likelihood of having an elevated CA-125 level at ovarian cancer diagnosis was lower for American Indian, Asian, or Black patients versus White patients. HealthDay News — Black and American Indian ...

The value of the serum tumour marker CA 125 to date has been in the monitoring of ovarian cancer patients for response to therapy and for recurrence of disease. However, despite the availability of ...

Should I ask my doctor for a CA 125 blood test to screen for ovarian cancer? Answer From Shannon K. Laughlin-Tommaso, M.D. The cancer antigen 125 (CA 125) blood test isn't recommended for women with ...

Key points A 20-year-old pediatric cancer survivor presented to her local oncology centre in southwestern Ontario with right supraclavicular adenopathy. She had a history of stage IIA Hodgkin lymphoma ...